BRPI0921921A2 - método para avaliar a condição renal em um indivíduo, e, uso de um ou mais marcadores de lesão renal. - Google Patents

método para avaliar a condição renal em um indivíduo, e, uso de um ou mais marcadores de lesão renal.

Info

Publication number
BRPI0921921A2
BRPI0921921A2 BRPI0921921A BRPI0921921A BRPI0921921A2 BR PI0921921 A2 BRPI0921921 A2 BR PI0921921A2 BR PI0921921 A BRPI0921921 A BR PI0921921A BR PI0921921 A BRPI0921921 A BR PI0921921A BR PI0921921 A2 BRPI0921921 A2 BR PI0921921A2
Authority
BR
Brazil
Prior art keywords
renal
markers
individual
assessing
condition
Prior art date
Application number
BRPI0921921A
Other languages
English (en)
Inventor
Gray Jeff
Anderberg Joseph
Nakamura Kevin
Mcpherson Paul
Original Assignee
Astute Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astute Medical Inc filed Critical Astute Medical Inc
Publication of BRPI0921921A2 publication Critical patent/BRPI0921921A2/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/34Genitourinary disorders
    • G01N2800/347Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0921921A 2008-11-22 2009-11-21 método para avaliar a condição renal em um indivíduo, e, uso de um ou mais marcadores de lesão renal. BRPI0921921A2 (pt)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US11714208P 2008-11-22 2008-11-22
US11714708P 2008-11-22 2008-11-22
US11716508P 2008-11-22 2008-11-22
US11713708P 2008-11-22 2008-11-22
US11716408P 2008-11-22 2008-11-22
US11717408P 2008-11-22 2008-11-22
US11717108P 2008-11-22 2008-11-22
US11716608P 2008-11-22 2008-11-22
US11717008P 2008-11-22 2008-11-22
US11715908P 2008-11-22 2008-11-22
PCT/US2009/065419 WO2010059996A1 (en) 2008-11-22 2009-11-21 Methods and compositions for diagnosis and prognosis of renal injury and renal failure

Publications (1)

Publication Number Publication Date
BRPI0921921A2 true BRPI0921921A2 (pt) 2019-09-24

Family

ID=42198524

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0921921A BRPI0921921A2 (pt) 2008-11-22 2009-11-21 método para avaliar a condição renal em um indivíduo, e, uso de um ou mais marcadores de lesão renal.

Country Status (13)

Country Link
US (1) US20110229915A1 (pt)
EP (2) EP2811036A3 (pt)
JP (2) JP5735922B2 (pt)
KR (1) KR20110097850A (pt)
CN (3) CN104034901A (pt)
AU (1) AU2009316387B2 (pt)
BR (1) BRPI0921921A2 (pt)
CA (1) CA2743253A1 (pt)
ES (1) ES2528799T3 (pt)
HK (1) HK1199931A1 (pt)
MX (1) MX2011005379A (pt)
NZ (2) NZ592552A (pt)
WO (1) WO2010059996A1 (pt)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180090396A (ko) 2008-01-18 2018-08-10 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 체액 내에서 질병 또는 병태의 시그너쳐의 검출 방법
AU2011269847A1 (en) 2010-02-26 2013-01-31 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
MX2013000220A (es) * 2010-06-23 2013-03-22 Astute Medical Inc Metodos y composiciones para diagnóstico y pronóstico de lesión renal e insuficiencia renal.
EP2585827A4 (en) 2010-06-23 2013-12-04 Astute Medical Inc METHOD AND COMPOSITIONS FOR DIAGNOSIS AND FORECASTING kidney injury and kidney insufficiency
CA2806296A1 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods of detecting kidney-associated diseases or conditions
AU2011280997A1 (en) 2010-07-23 2013-02-28 President And Fellows Of Harvard College Methods of detecting autoimmune or immune-related diseases or conditions
AU2011280936A1 (en) 2010-07-23 2013-02-28 President And Fellows Of Harvard College Methods of detecting prenatal or pregnancy-related diseases or conditions
AU2011280944A1 (en) 2010-07-23 2013-02-28 President And Fellows Of Harvard College Methods of detecting diseases or conditions using phagocytic cells
MX382244B (es) 2010-07-23 2025-03-13 Harvard College Metodos para detectar firmas de enfermedad o condiciones en fluidos corporales
US10557856B2 (en) * 2010-09-24 2020-02-11 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Biomarkers of renal injury
EA201390293A1 (ru) * 2010-10-07 2013-09-30 Астьют Медикал, Инк. Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности
EP3828544A1 (en) * 2011-01-08 2021-06-02 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US20150168422A1 (en) * 2011-05-12 2015-06-18 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2013009573A1 (en) * 2011-07-09 2013-01-17 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
NZ771629A (en) 2013-03-09 2022-12-23 Harry Stylli Methods of detecting cancer
EP2965086A4 (en) 2013-03-09 2017-02-08 Harry Stylli Methods of detecting prostate cancer
CA3184836A1 (en) * 2013-05-14 2014-11-20 Metabolon, Inc. Biomarkers related to kidney function and methods using the same
CA2929444C (en) * 2013-11-04 2023-12-19 F. Hoffmann-La Roche Ag Biomarkers and methods for progression prediction for chronic kidney disease
WO2015153860A1 (en) * 2014-04-04 2015-10-08 Somalogic, Inc. Glomerular filtration rate biomarkers and uses thereof
WO2016040843A1 (en) 2014-09-11 2016-03-17 Harry Stylli Methods of detecting prostate cancer
CN107003320B (zh) * 2014-11-25 2021-08-17 豪夫迈·罗氏有限公司 慢性肾脏疾病的快速进展的生物标志物
WO2018117011A1 (ja) 2016-12-19 2018-06-28 国立大学法人大阪大学 インビトロでのIgM型メモリーB細胞分化培養系を用いた臓器移植後抗体関連型拒絶反応の早期診断法
EP3686286B1 (en) * 2017-09-20 2023-11-08 Oncolock Co., Ltd. Ovarian cancer biomarker and use thereof
KR102036219B1 (ko) 2019-05-07 2019-10-24 서울대학교병원 유전자 프로모터의 CpG 메틸화 변화를 이용한 만성신장질환의 악화 예측용 조성물 및 이의 이용
KR102036221B1 (ko) 2019-05-07 2019-10-24 서울대학교병원 만성신장질환의 예후 예측을 위한 후성 유전학적 진단 키트 개발
KR102036222B1 (ko) 2019-05-07 2019-10-24 서울대학교병원 당뇨병성 신증에 의한 만성신장질환 환자의 예후 예측용 마커
KR102036220B1 (ko) 2019-05-07 2019-10-24 서울대학교병원 만성신장질환 특이적 후성학적 메틸화 마커 검출용 조성물 및 검출방법
KR102189144B1 (ko) 2020-10-15 2020-12-09 서울대학교병원 만성신장질환 악화 예측 마커 및 이를 이용한 악화 예측 방법
KR102189142B1 (ko) 2020-10-15 2020-12-09 서울대학교병원 만성신장질환의 악화 예측 마커로서의 snp 및 이의 이용
KR102189143B1 (ko) 2020-10-15 2020-12-09 서울대학교병원 만성신장질환 예후 예측을 위한 조성물 및 방법
CN115963269A (zh) * 2021-10-09 2023-04-14 北京大学第一医院 尿调蛋白Sda抗原水平在预测早期肾损伤中的应用
CN115754304A (zh) * 2022-11-24 2023-03-07 重庆医科大学 骨形态蛋白-7作为生物标志物在脓毒血症诊断、预后或治疗监测中的用途
CN118160679B (zh) * 2024-04-03 2025-11-04 广东药科大学 一种糖尿病合并肾脏脂质损伤动物模型的构建方法

Family Cites Families (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5028535A (en) 1989-01-10 1991-07-02 Biosite Diagnostics, Inc. Threshold ligand-receptor assay
US5939272A (en) 1989-01-10 1999-08-17 Biosite Diagnostics Incorporated Non-competitive threshold ligand-receptor assays
US5922615A (en) 1990-03-12 1999-07-13 Biosite Diagnostics Incorporated Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network
JPH05504841A (ja) 1990-09-14 1993-07-22 バイオサイト・ダイアグノスティックス・インコーポレイテッド リガンドレセプター及びリガンドのコンプレックスに対する抗体及びリガンド―レセプターアッセーでのそれらの用途
US5955377A (en) 1991-02-11 1999-09-21 Biostar, Inc. Methods and kits for the amplification of thin film based assays
WO1992018868A1 (en) 1991-04-10 1992-10-29 Biosite Diagnostics Incorporated Crosstalk inhibitors and their uses
ATE195808T1 (de) 1991-04-12 2000-09-15 Biosite Diagnostics Inc Neue konjugate und testverfahren für die gleichzeitige bestimmung von multiplen liganden
US6143576A (en) 1992-05-21 2000-11-07 Biosite Diagnostics, Inc. Non-porous diagnostic devices for the controlled movement of reagents
US6019944A (en) 1992-05-21 2000-02-01 Biosite Diagnostics, Inc. Diagnostic devices and apparatus for the controlled movement of reagents without membranes
US5494829A (en) 1992-07-31 1996-02-27 Biostar, Inc. Devices and methods for detection of an analyte based upon light interference
US5824799A (en) 1993-09-24 1998-10-20 Biosite Diagnostics Incorporated Hybrid phthalocyanine derivatives and their uses
US6498142B1 (en) * 1996-05-06 2002-12-24 Curis, Inc. Morphogen treatment for chronic renal failure
SK285461B6 (sk) * 1996-05-24 2007-02-01 Biogen Idec Ma Inc. Izolovaný polypeptid KIM, modulátor tkanivovej regenerácie a nukleová kyselina, ktorá ho kóduje, spôsob prípravy polypeptidu a farmaceutická kompozícia obsahujúca polypeptid
US6113855A (en) 1996-11-15 2000-09-05 Biosite Diagnostics, Inc. Devices comprising multiple capillarity inducing surfaces
US5947124A (en) 1997-03-11 1999-09-07 Biosite Diagnostics Incorporated Diagnostic for determining the time of a heart attack
US6057098A (en) 1997-04-04 2000-05-02 Biosite Diagnostics, Inc. Polyvalent display libraries
US20060223077A1 (en) * 1997-06-06 2006-10-05 Human Genome Sciences, Inc. 207 human secreted proteins
US6218122B1 (en) * 1998-06-19 2001-04-17 Rosetta Inpharmatics, Inc. Methods of monitoring disease states and therapies using gene expression profiles
US6958147B1 (en) * 1998-10-26 2005-10-25 Licentia Ltd Use of VEGF-C to prevent restenosis
BR9916407A (pt) * 1998-12-21 2001-09-25 Univ Monash Detecção e tratamento de doenças dos rins
WO2002054081A2 (en) * 2000-12-29 2002-07-11 Oxford Glycosciences (Uk) Limited Proteins, genes and their use for diagnosis and treatment of kidney response
JP2005300158A (ja) * 2001-03-26 2005-10-27 Nippon Shinyaku Co Ltd 増殖性糸球体腎炎の予防・治療用薬物のスクリーニング方法
US20060088823A1 (en) * 2001-03-29 2006-04-27 Brian Haab Microarray gene expression profiling in clear cell renal cell carcinoma : prognosis and drug target identification
US20070015146A1 (en) * 2001-05-22 2007-01-18 Gene Logic, Inc. Molecular nephrotoxicology modeling
US7235358B2 (en) * 2001-06-08 2007-06-26 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US20030003588A1 (en) * 2001-06-28 2003-01-02 Comper Wayne D. Method for kidney disease detection by protein profiling
CA2454342A1 (en) * 2001-07-24 2003-02-06 Yale University Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease
US6784154B2 (en) * 2001-11-01 2004-08-31 University Of Utah Research Foundation Method of use of erythropoietin to treat ischemic acute renal failure
US8404229B2 (en) * 2001-12-07 2013-03-26 Cytori Therapeutics, Inc. Methods of using adipose derived stem cells to treat acute tubular necrosis
US7442546B2 (en) * 2002-03-15 2008-10-28 The Regents Of The University Of Michigan Method of modulating inflammatory response
EP1532268A4 (en) * 2002-03-21 2006-07-05 Yissum Res Dev Co PERIPHERAL BLOOD CELL MARKERS SUITABLE FOR THE DIAGNOSIS OF MULTIPLE SCLEROSIS AND THESE USEFUL METHODS AND KITS
US7138229B2 (en) * 2002-12-06 2006-11-21 Renovar, Inc. Systems and methods for characterizing kidney diseases
US7138230B2 (en) * 2002-12-06 2006-11-21 Renovar, Inc. Systems and methods for characterizing kidney diseases
GB0215509D0 (en) * 2002-07-04 2002-08-14 Novartis Ag Marker genes
US6941172B2 (en) * 2002-11-18 2005-09-06 Zvi Nachum Method and device for restoring kidney function using electromagnetic stimulation
US20060063156A1 (en) * 2002-12-06 2006-03-23 Willman Cheryl L Outcome prediction and risk classification in childhood leukemia
EP1613273B1 (en) * 2003-04-11 2012-06-13 MedImmune, LLC Recombinant il-9 antibodies and uses thereof
WO2005002416A2 (en) * 2003-06-04 2005-01-13 Joslin Diabetes Center, Inc. Predictors of renal disease
US20050148029A1 (en) * 2003-09-29 2005-07-07 Biosite, Inc. Methods and compositions for determining treatment regimens in systemic inflammatory response syndromes
DE10349124A1 (de) * 2003-10-22 2005-05-19 Roche Diagnostics Gmbh Differenzialdiagnostik mit Hepcidin
GB0329288D0 (en) * 2003-12-18 2004-01-21 Inverness Medical Switzerland Monitoring method and apparatus
WO2005103281A2 (en) * 2004-04-26 2005-11-03 Children's Medical Center Corporation Platelet biomarkers for the detection of disease
US20050272101A1 (en) * 2004-06-07 2005-12-08 Prasad Devarajan Method for the early detection of renal injury
US7588892B2 (en) * 2004-07-19 2009-09-15 Entelos, Inc. Reagent sets and gene signatures for renal tubule injury
US20080038192A1 (en) * 2004-07-19 2008-02-14 Neurochem Inc. Diagnostic Methods Of Multiple Organ Amyloidosis
US7141382B1 (en) * 2004-10-12 2006-11-28 Parikh Chirag R Methods for detection of IL-18 as an early marker for diagnosis of acute renal failure and predictor of mortality
US20090258002A1 (en) * 2005-02-01 2009-10-15 Government Of The Us, As Represented By The Secretary, Department Of Health And Human Services Biomarkers for Tissue Status
EP2604703B1 (en) * 2005-03-14 2017-02-01 The Board of Trustees of the Leland Stanford Junior University Methods for evaluating graft survival in a solid organ transplant recipient
US7608413B1 (en) * 2005-03-25 2009-10-27 Celera Corporation Kidney disease targets and uses thereof
US20070037232A1 (en) * 2005-03-31 2007-02-15 Barasch Jonathan M Detection of NGAL in chronic renal disease
SG2014011837A (en) * 2005-04-18 2014-04-28 Mitomics Inc Mitochondrial mutations and rearrangements as a diagnostic tool for the detection of sun exposure, prostate cancer and other cancers
US20070087387A1 (en) * 2005-04-21 2007-04-19 Prasad Devarajan Method for the Early Detection of Renal Disease Using Proteomics
RS51845B (sr) * 2005-04-22 2012-02-29 Eli Lilly And Company Specifična tgf beta 1 antitela
US7833732B2 (en) * 2005-07-21 2010-11-16 The John Hopkins University Acute renal injury
US7759077B2 (en) * 2005-08-02 2010-07-20 Shariat Shahrokh F Soluble fas urinary marker for the detection of bladder transitional cell carcinoma
DE102006033004A1 (de) * 2005-08-09 2007-09-13 Löcker, Christian Klopfvorrichtung und -verfahren
EP1757940A1 (en) * 2005-08-26 2007-02-28 Cézanne S.A.S. In vitro method for diagnosing and monitoring renal cell carcinoma (RCC) using MMP-7 as humoral biomarker for RCC
ES2343276T3 (es) * 2005-09-02 2010-07-27 Toray Industries, Inc. Kit y metodo para la deteccion del cancer urotelial.
US20080090304A1 (en) * 2006-10-13 2008-04-17 Barasch Jonathan Matthew Diagnosis and monitoring of chronic renal disease using ngal
US8329408B2 (en) * 2005-10-31 2012-12-11 Bayer Healthcare Llc Methods for prognosis and monitoring cancer therapy
US10716749B2 (en) * 2005-11-03 2020-07-21 Palo Alto Investors Methods and compositions for treating a renal disease condition in a subject
US7771995B2 (en) * 2005-11-14 2010-08-10 Merial Limited Plasmid encoding human BMP-7
US20080133141A1 (en) * 2005-12-22 2008-06-05 Frost Stephen J Weighted Scoring Methods and Use Thereof in Screening
TW200726845A (en) * 2006-01-02 2007-07-16 Nat Defense Medical Ct Biomarker molecular of renal illness and detecting method for the same
GB0605217D0 (en) * 2006-03-15 2006-04-26 Novartis Ag Method and compositions for assessing acute rejection
GB0606776D0 (en) * 2006-04-03 2006-05-10 Novartis Pharma Ag Predictive biomarkers for chronic allograft nephropathy
US7662578B2 (en) * 2006-04-21 2010-02-16 Children's Hospital Medical Center Method and kit for the early detection of impaired renal status
US20080038269A1 (en) * 2006-05-25 2008-02-14 Mount Sinai Hospital Methods for detecting and treating kidney disease
WO2008005375A2 (en) * 2006-06-30 2008-01-10 Merck & Co., Inc. Kidney toxicity biomarkers
EP2049713A4 (en) * 2006-07-21 2010-06-16 Univ Alberta tissue rejection
GB0617429D0 (en) * 2006-09-05 2006-10-18 Electrophoretics Ltd Markers of renal transplant rejection and renal damage
US20080206794A1 (en) * 2006-09-15 2008-08-28 Renovar Incorporated Systems And Methods For Characterizing Contrast Induced-Nephropathy
WO2008060607A2 (en) * 2006-11-14 2008-05-22 Biosite Incorporated Methods and compositions for monitoring and risk prediction in cardiorenal syndrome
WO2008073899A2 (en) * 2006-12-08 2008-06-19 The Children's Hospital Of Philadelphia Prrg4-associated compositions and methods of use thereof in methods of tumor diagnosis
GB0701626D0 (en) * 2007-01-22 2007-03-07 Cambridge Entpr Ltd Methods and biomarkers for diagnosing and monitoring psychotic disorders
US8221995B2 (en) * 2007-03-23 2012-07-17 Seok-Won Lee Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes
ES2532221T3 (es) * 2007-03-26 2015-03-25 Novartis Ag Biomarcadores de seguridad renal predictiva y señales de biomarcadores para monitorizar la función renal
US8080394B2 (en) * 2007-04-27 2011-12-20 Brigham And Women's Hospital Method for determining predisposition to pulmonary infection
US9091695B2 (en) * 2007-06-01 2015-07-28 Laboratory Corporation Of America Holdings Methods and systems for quantification of peptides and other analytes
US20090047689A1 (en) * 2007-06-20 2009-02-19 John Kolman Autoantigen biomarkers for early diagnosis of lung adenocarcinoma
US20100267041A1 (en) * 2007-09-14 2010-10-21 Predictive Biosciences, Inc. Serial analysis of biomarkers for disease diagnosis
WO2009039421A1 (en) * 2007-09-20 2009-03-26 University Of Louisville Research Foundation, Inc. Peptide biomarkers predictive of renal function decline and kidney disease
WO2009038742A2 (en) * 2007-09-20 2009-03-26 Caritas St. Elizabeth's Medical Center Of Boston, Inc. Method for estimating risk of acute kidney injury
US8003333B2 (en) * 2007-09-28 2011-08-23 Mayo Foundation For Medical Education And Research Serum biomarkers for early detection of acute cellular rejection
EP2261660B1 (en) * 2008-02-29 2013-08-07 National University Corporation Nagoya University Biomarker for the estimation of acute renal disorder and prognosis of the disorder, and use of the biomarker
US20090298106A1 (en) * 2008-05-30 2009-12-03 Therapeutic Monitoring Services, L.L.C. Methods for Monitoring Immunosuppressant Drug Levels, Renal Function, and Hepatic Function Using Small Volume Samples
US8241861B1 (en) * 2008-07-08 2012-08-14 Insilicos, Llc Methods and compositions for diagnosis or prognosis of cardiovascular disease
EP2149613A1 (en) * 2008-07-28 2010-02-03 Greenwood Genetic Center, Inc. Methods for determining dysregulation of methylation of brain expressed genes on the X chromosome to diagnose autism spectrum disorders
US8673574B2 (en) * 2008-08-21 2014-03-18 Pxbiosciences Llc Diagnosis and monitoring of renal failure using peptide biomarkers
BRPI0917711A2 (pt) * 2008-08-28 2017-06-20 Astute Medical Inc método para avaliar o estado renal em um paciente, e, uso de um ou mais marcadores de lesão renal
EP2324354B1 (en) * 2008-08-29 2014-07-16 Astute Medical, Inc. Methods for prognosis of acute renal failure
US8501489B2 (en) * 2008-09-26 2013-08-06 University of Pittsburgh—of the Commonwealth System of Higher Education Urinary biomarkers to predict long-term dialysis
NZ619918A (en) * 2008-10-21 2015-04-24 Astute Medical Inc Methods and compositions for diagnosis and prognosis of renal injury and renal failure
CN104391115B (zh) * 2008-10-21 2017-04-19 阿斯图特医药公司 用于诊断和预后肾损伤和肾衰竭的方法和组合物
US8052960B2 (en) * 2009-01-20 2011-11-08 The Penn State Research Foundation Netrin-1 as a biomarker of injury and disease
US9229010B2 (en) * 2009-02-06 2016-01-05 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2011017685A1 (en) * 2009-08-07 2011-02-10 Rules-Based Medicine, Inc. Methods and devices for detecting kidney transplant rejection
NZ630277A (en) * 2009-09-21 2015-02-27 Astute Medical Inc Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US20130035290A1 (en) * 2011-05-17 2013-02-07 Yale University Chitinase-3-Like Protein 1 as a Biomarker of Recovery from Kidney Injury

Also Published As

Publication number Publication date
AU2009316387B2 (en) 2015-01-29
NZ592552A (en) 2013-12-20
HK1199931A1 (en) 2015-07-24
CN103439510A (zh) 2013-12-11
NZ604873A (en) 2014-05-30
JP2015064381A (ja) 2015-04-09
CN103439510B (zh) 2016-09-14
US20110229915A1 (en) 2011-09-22
JP5735922B2 (ja) 2015-06-17
JP2012510058A (ja) 2012-04-26
AU2009316387A1 (en) 2010-05-27
ES2528799T3 (es) 2015-02-12
MX2011005379A (es) 2011-06-09
EP2364370A4 (en) 2012-03-21
EP2811036A3 (en) 2015-02-18
CN104034901A (zh) 2014-09-10
EP2364370B1 (en) 2014-09-03
CN102272328B (zh) 2014-06-18
CA2743253A1 (en) 2010-05-27
EP2364370A1 (en) 2011-09-14
EP2811036A2 (en) 2014-12-10
HK1161901A1 (en) 2012-08-10
KR20110097850A (ko) 2011-08-31
WO2010059996A1 (en) 2010-05-27
CN102272328A (zh) 2011-12-07

Similar Documents

Publication Publication Date Title
BRPI0921921A2 (pt) método para avaliar a condição renal em um indivíduo, e, uso de um ou mais marcadores de lesão renal.
BRPI0922021A2 (pt) método para avaliar a condição renal em um indivíduo, e, uso de um ou mais marcadores de lesão renal
BRPI0919640A2 (pt) método para avaliar a situação renal em um indivíduo, e, uso de um ou mais marcadores de lesão renal
BRPI0917711A2 (pt) método para avaliar o estado renal em um paciente, e, uso de um ou mais marcadores de lesão renal
BRPI1007917A2 (pt) método para avaliar a situação renal em um indivíduo, e, uso de um ou mais marcadores de lesão renal
BRPI0816349A2 (pt) sistema, sistema para uso em um poço, e método
BRPI0820148A2 (pt) Sistema de aberturas, sistema de computador e método para usinar aberturas
BRPI0909002A2 (pt) aparelho para uso em um poço, sistema, e método para uso em um poço
BRPI0821452A2 (pt) Método para processar um ou mais hidrocarbonetos, e, sistema para processar hidrocarbonetos
BRPI0821334A2 (pt) método utilizável em um poço, e sistema utilizável com um poço.
NL2003118A1 (nl) Alignment system, lithographic system and method.
BRPI0912426A2 (pt) método executado por computador, computador, e sistema para uso com poço
BRPI0921579A2 (pt) método para ligar dinamicamente programa em plataforma embutida e plataforma embutida
BRPI0919935A2 (pt) método para executar testes de avaliação de audição usando uma rede de computador, e, sistema de teleaudição
BRPI0917639A2 (pt) aparelho utilizável em umpoço, e método utilizável em um poço.
BRPI0915433A2 (pt) método, e, dispositivo.
BRPI0720695A2 (pt) Compostos e métodos para modulação de cinase, e indicações para estes
BRPI1016158A2 (pt) "sistema e método para monitorar um desempenho atlético, e, sistema e método de monitoramento do desempenho atlético."
BRPI0815318A2 (pt) "método e sistema para avaliação de uma condição de um componente".
BRPI0817402A2 (pt) dispositivos e métodos para automação de fluxos de trabalho, adaptação e integração
BRPI0821781A2 (pt) Sistemas e métodos para localizar um dispositivo móvel.
BRPI0813216A2 (pt) Inibidores de proteínas cinases e métodos para usá-los.
BRPI0819085A2 (pt) Sistema para uso com produção de hidrocarbonetos, e, método associado com produção de hidrocarbonetos
BRPI0807476A2 (pt) Aparelho eletrônico, e, método de detecção de laço para uso em um aparelho eletrônico.
BRPI0812011A2 (pt) Sistema e método para gerenciamento de dados de saúde.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.